Streetbeat News

Stock Prices

ACAD

Acadia Pharmaceuticals has projected its FY24 total revenue to be in the range of $930 million to $980 million, compared to the estimated $953.15 million.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:30 pm

AQST

Aquestive Therapeutics (NASDAQ:AQST) reported Q2 2024 GAAP EPS of $(0.03), beating the $(0.11) estimate. Sales were $20.099M, surpassing the $12.380M estimate and showing a 51.79% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:30 pm

BJ

BJ's Wholesale Club (NYSE:BJ) has significantly outperformed the market over the past 5 years, with an annualized return of 31.23%. A $1000 investment in BJ 5 years ago would be worth $3,674.28 today. The company currently has a market capitalization of $11.32 billion.

Portfolio Pulse from Benzinga Insights

August 06, 2024 | 9:30 pm

MCK

McKesson (NYSE:MCK) has significantly outperformed the market over the past 5 years, delivering an average annual return of 33.9%. A $100 investment in MCK 5 years ago would be worth $438.21 today. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

August 06, 2024 | 9:30 pm

SGMO

Sangamo Therapeutics (NASDAQ:SGMO) reported Q2 2024 GAAP EPS of $(0.18), missing the $(0.16) estimate. Sales were $356,000, significantly below the $8.26 million estimate and down 94.79% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:29 pm

IFF

International Flavors & Fragrances shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 net sales guidance.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:28 pm

CART

Maplebear Inc (NASDAQ:CART) reported better-than-expected Q2 earnings, with revenue of $823 million and EPS of 20 cents, surpassing estimates. The company also issued strong guidance for Q3, leading to an 8.59% increase in after-hours trading.

Portfolio Pulse from Adam Eckert

August 06, 2024 | 9:28 pm

EOSE

Eos Energy Enterprises (NASDAQ:EOSE) reported Q2 2024 GAAP EPS of $(0.25), missing the $(0.17) estimate by 47.06%. Sales were $898K, missing the $3.795M estimate by 76.34%, but up 260.64% from $249K last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:28 pm

RIVN

Rivian Automotive shares are trading lower after the company reported worse-than-expected Q2 adjusted EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:27 pm

NVRO

Nevro Corp. has projected its FY24 adjusted EBITDA to be between $(20M) and $(18M), indicating a negative outlook for the company's financial performance in the upcoming fiscal year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:27 pm